TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T16555	P2Y purinoceptor 14	B1RUX8	Uridine-5'-Diphosphate-2-Deoxy-2-Fluoro-alpha-D-Glucose	Investigative	448923	C15H23FN2O16P2	568.29	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)F)O)O	EC50 = 2500000 nM	Non binder
T16555	P2Y purinoceptor 14	B4CJ9M	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	Investigative	448872	C15H23FN2O16P2	568.29	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)F)O)O)O)O	EC50 = 567000 nM	Non binder
T16555	P2Y purinoceptor 14	BA5CZ6	Cyclohexyl [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate	Investigative	44627698	C15H24N2O12P2	486.3	C1CCC(CC1)OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O	EC50 = 5160000 nM	Non binder
T16555	P2Y purinoceptor 14	BG5IO3	Uridine 5'-diphosphoric acid beta-(3-fluoro-3-deoxy-alpha-D-glucopyranosyl) ester	Investigative	24858471	C15H23FN2O16P2	568.29	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)F)O)O)O	EC50 = 361000 nM	Non binder
T16555	P2Y purinoceptor 14	BY86BD	[[(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6S)-6-(fluoromethyl)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate	Investigative	46226455	C15H23FN2O16P2	568.29	C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CF)O)O)O)O)O	EC50 = 905000 nM	Non binder